Korczowski Bartosz, Gabinet Lekarski — Clinical Trial Site

12 Registered trials

6 Currently recruiting

Organisation

Korczowski Bartosz, Gabinet Lekarski

Location

Rzeszow, Poland

Identifier

ORL-000000014

Address

ul. Litewska 4A/7, 35-302, Poland

Departments

Korczowski Bartosz, Gabinet Lekarski
N/A
NA

Clinical trials at this site (12)

Search interface

A Study to Learn How Well Dupilumab Works in Adult and Adolescent Participants with Eosinophilic Gastritis with or without Eosinophilic Duod… Recruiting

2022-500795-62-00 Eosinophilic gastritis 4 2024-03-25
OPEN LABEL, MAINTENANCE STUDY OF ORAL TOFACITINIB IN CHILDREN WITH MODERATE TO SEVERE ULCERATIVE COLITIS Recruiting

2023-509694-22-00 Ulcerative Colitis (UC) 5 2022-01-26
A Study to Test the Effectiveness and Safety of RO7790121 for induction and maintenance therapy in Patients with Moderately to Severely Acti… Recruiting

2024-513053-69-00 Moderately to Severely Active Crohn's Disease (CD) 5 2025-04-16
A Long-term Extension Study of Guselkumab in Pediatric Participants Recruiting

2023-509560-16-00 Moderately to severely active ulcerative colitis (UC) 5 2024-10-29
A study to discover if ZED1227 can improve continued celiac disease symptoms despite a gluten-free diet Recruiting

2023-506150-21-00 Celiac Disease 4 2024-05-29
A Long-term Study in Children and Teenagers with Ulcerative Colitis or Crohn’s Disease treated with Vedolizumab IV Recruiting

2023-509046-36-00 Active Ulcerative Colitis (UC) or Crohn's disease (CD) 5 2023-04-26
Efficacy, Safety, and Pharmacokinetics of Guselkumab in Pediatric Participants with Moderately to Severely Active Ulcerative Colitis Ended

2022-502238-22-00 Ulcerative Colitis 5 2024-05-14
A Phase 3, Multicenter, Open-label, Basket, Long-term Extension Study of Ustekinumab in Pediatric Clinical Study Participants (2 to <18 Year… Ended

2022-501067-40-00 Moderately to Severely Active Ulcerative Colitis 5 2021-11-30
A study to compare the effect of AVT16 and Entyvio® in subjects with moderate to severe active ulcerative colitis. Ended

2023-507705-34-00 Moderate to Severe Active Ulcerative Colitis 5 2025-08-29
A Global, Open-label, Adaptive Design Study to Investigate the Efficacy and Safety of SerpinPC in Subjects With Severe Hemophilia A or Moder… Ended

2022-502880-39-00 Severe Hemophilia A or Moderately Severe to Severe Hemo 4 2023-11-13
Clinical Study of the Efficacy, Safety and Pharmacokinetics of Ustekinumab as Intravenous Induction Treatment Followed by Subcutaneous Ustek… Ended

2023-504978-38-00 Moderately to Severely Active Crohn's Disease 5 2021-03-16
A Clinical Study of the Efficacy, Safety and Pharmacokinetics of Ustekinumab as Intravenous Induction Treatment Followed by Subcutaneous Ust… Ended

2023-504977-19-00 Moderately to Severely Active Ulcerative Colitis 5 2021-03-15